LeMaitre Vascular, Inc. (NASDAQ:LMAT) Median Sales Estimate At $22.76


The EPS projection of LeMaitre Vascular, Inc. (NASDAQ:LMAT) for quarter ended 2016-09-30 is $0.12. Last week, the projection for EPS was $0.12 against target of $0.12, a month earlier. While 2-months ago, this projection was $0.12 versus forecast of $0.12a quarter months earlier, posting a deviation of 0%.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted that 18 days earlier, the share price was revised 2 times on upside. In addition, negative revisions were 0.

In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 2, and 2, correspondingly.

The per-share earnings downgrade for LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.

Earnings Surprises

LeMaitre Vascular, Inc. (NASDAQ:LMAT) EPS target was $0.12 for the quarter closed 1. It was based on 3 calls. As on 2016-05-02 the EPS was $0.11. The change was $0.01, posting a deviation of 10%. The price projections gave a standard deviation of 0.

Quarterly Sales Estimates

LeMaitre Vascular, Inc. (NASDAQ:LMAT) sales prediction for the fiscal 2016 stands at $22.716 and the median estimate is at $22.76. Almost 3 analysts gave sales target.

Among this, the highest sales estimate is $22.8 while the lowest target is $22.59 showing standard deviation of 0.111%.

As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.

Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.

A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of 1.774%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 14 times, 1 visits today)